Toxic Industrial Chemical Linked to Deaths of 23 Children in India Cough Syrup Tragedy
Table of Contents
A deadly batch of cough syrup contaminated with diethylene glycol, a toxic chemical commonly found in brake fluid and antifreeze, has been linked to the deaths of 23 children in Madhya Pradesh, India. The revelation,confirmed by investigators on October 11,2025,has ignited a fresh wave of scrutiny over pharmaceutical oversight and supply chain security.
The tragedy, centered in the Chhindwara district with 20 of the deaths occurring there, first came to light on October 7, 2025, with early reporting from India Today journalist Ravish Pal Singh in Bhopal, who detailed the rising death toll and connected the fatalities to the Coldrif cough syrup.
Source of Contamination Identified
The Special investigation Team (SIT) has traced the source of the contamination to Sresan Pharmaceuticals, a company owned by Ranganathan Govindan in Tamil Nadu. According to the SIT investigation, Govindan allegedly procured banned industrial-grade diethylene glycol for use in the production of the syrup.
“The chemical was traced directly to Sresan Pharmaceuticals,” a senior official stated.”We are investigating how a banned substance entered the manufacturing process.”
Mapping the Supply Chain
Investigators are now undertaking a comprehensive review of the entire supply chain, from the initial sourcing of raw materials to the final distribution of the Coldrif syrup. The goal is to determine the duration of the contamination and identify any additional parties who may have been involved.
“We aim to fix obligation at every stage,” the official added, “including suppliers, intermediaries, and those responsible for production oversight.”
Company Response and Initial Claims
Govindan initially claimed ignorance regarding the presence of the toxic chemical, stating that production responsibilities had been delegated. However, authorities are skeptical and are pursuing a thorough investigation into his claims.
Regulatory Implications and Calls for Reform
This incident is not isolated. It echoes previous tragedies involving contaminated syrups and underscores the urgent need for reform in drug manufacturing protocols and raw material traceability. The case has reignited calls for tighter pharmaceutical oversight to prevent future occurrences.
“This tragedy highlights systemic vulnerabilities in the pharmaceutical supply chain,” one analyst noted. “Increased regulation and stringent quality control measures are essential to protect public health.”
The investigation is ongoing, and authorities are committed to holding all responsible parties accountable for their actions. The Coldrif cough syrup tragedy serves as a stark reminder of the devastating consequences of compromised pharmaceutical safety standards.
Why did this happen? The deaths of 23 children in India were caused by a batch of Coldrif cough syrup contaminated with diethylene glycol, a toxic chemical used in brake fluid and antifreeze. Sresan Pharmaceuticals, owned by Ranganathan Govindan, allegedly procured banned industrial-grade diethylene glycol for use in production.
who was involved? The key players include Sresan Pharmaceuticals and its owner, Ranganathan Govindan, who are under investigation. The Special Investigation Team (SIT) is leading the investigation, and authorities are seeking to identify any additional parties involved in the supply chain. Ravish Pal Singh, a journalist with India Today, was
